1
|
Hasan N, Pollack A and Cho I: Infectious
causes of colorectal cancer. Infect Dis Clin North Am.
24:1019–1039. 2010. View Article : Google Scholar
|
2
|
Thirlwell C, Will OC, Domingo E, et al:
Clonality assessment and clonal ordering of individual neoplastic
crypts shows polyclonality of colorectal adenomas.
Gastroenterology. 138:1441–1454. 2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Winawer SJ, Zauber AG, Ho MN, et al:
Prevention of colorectal cancer by colonoscopic polypectomy. The
National Polyp Study Workgroup. N Engl J Med. 329:1977–1981. 1993.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Arber N, Spicak J, Rácz I, et al:
Five-year analysis of the prevention of colorectal sporadic
adenomatous polyps trial. Am J Gastroenterol. 106:1135–1146.
2011.PubMed/NCBI
|
5
|
Leung WK, Tang V and Lui PC: Detection
rates of proximal or large serrated polyps in Chinese patients
undergoing screening colonoscopy. J Dig Dis. 13:466–471. 2012.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Hortin GL: The MALDI-TOF mass
spectrometric view of the plasma proteome and peptidome. Clin Chem.
52:1223–1237. 2006. View Article : Google Scholar : PubMed/NCBI
|
7
|
Terracciano R, Pasqua L, Casadonte F, et
al: Derivatized mesoporous silica beads for MALDI-TOF MS profiling
of human plasma and urine. Bioconjug Chem. 20:913–923. 2009.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Zheng SZ and Zou SQ: The application of
comparative proteomics in study of tumor marker. Zhong Guo Pu Wai
Ji Chu Yu Lin Chuang Za Zhi. 12:147–149. 2008.
|
9
|
Gast MC, Schellens JH and Beijnen JH:
Clinical proteomics in breast cancer: a review. Breast Cancer Res
Treat. 116:17–29. 2009. View Article : Google Scholar : PubMed/NCBI
|
10
|
Ahram M: An introduction into proteomics
and its clinical applications. Saudi Med J. 28:499–507.
2007.PubMed/NCBI
|
11
|
Xu SY, Liu Z, Ma WJ, Sheyhidin I, Zheng ST
and Lu XM: New potential biomarkers in the diagnosis of esophageal
squamous cell carcinoma. Biomarkers. 14:340–346. 2009. View Article : Google Scholar : PubMed/NCBI
|
12
|
Issaq HJ, Fox SD, Chan KC and Veenstra TD:
Global proteomics and metabolomics in cancer biomarker discovery. J
Sep Sci. 34:3484–3492. 2011. View Article : Google Scholar : PubMed/NCBI
|
13
|
Schipper R, Loof A, de Groot J, Harthoorn
L, Dransfield E and van Heerde W: SELDI-TOF-MS of saliva:
methodology and pre-treatment effects. J Chromatogr B Analyt
Technol Biomed Life Sci. 847:45–53. 2007. View Article : Google Scholar : PubMed/NCBI
|
14
|
Fuchs B, Schiller J, Süss R, et al:
Analysis of stem cell lipids by offline HPTLC-MALDI-TOF MS. Anal
Bioanal Chem. 392:849–860. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Sun CY, Zang YC, San YX, Sun W and Zhang
L: Proteomic analysis of clear cell renal cell carcinoma.
Identification of potential tumor markers. Saudi Med J. 31:525–532.
2010.PubMed/NCBI
|
16
|
Schipper R, Loof A, de Groot J, Harthoorn
L, van Heerde W and Dransfield E: Salivary protein/peptide
profiling with SELDI-TOF-MS. Ann NY Acad Sci. 1098:498–503. 2007.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Grizzle WE, Semmes OJ, Basler J, et al:
The early detection research network surface-enhanced laser
desorption and ionization prostate cancer detection study: A study
in biomarker validation in genitourinary oncology. Urol Oncol.
22:337–343. 2004. View Article : Google Scholar
|
18
|
Brenner H, Chang-Claude J, Rickert A,
Seiler CM and Hoffmeister M: Risk of colorectal cancer after
detection and removal of adenomas at colonoscopy: population-based
case-control study. J Clin Oncol. 30:2969–2976. 2012. View Article : Google Scholar : PubMed/NCBI
|
19
|
Rüth S, Spatz J and Anthuber M: Colorectal
adenoma: pro conventional/laparoscopic resection. Chirurg.
82:520–525. 2011.(In German).
|